Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20180203038599N1
IRCT20180203038599N1
Completed
Phase 2

Comparison of the Efficacy of Intradermal injected Tranexamic Acid vs Hydroquinone cream in the Treatment of Melasma

Ahvaz University of Medical Sciences0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Women at the range of 18 to 50 years old
  • •with symmetrical bilateral melasma
  • •who signature the letter of satisfaction

Exclusion Criteria

  • •Pregnant and lactating women
  • •Oral contraceptive pill consumption in 12 months ago during RCT
  • •History of coagulopathy and thrombotic disorder
  • •Anticoagulant and antiepileptic drug consumption
  • •Sensitivity to tranexamic acid
  • •History of treatment for melasma during 1 month ago
  • •Active facial herpes simplex virus infection
  • •Facial wart

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Effect of Ascorbic acid in treatment of melasma
IRCT20191213045719N1Ahvaz University of Medical Sciences24
Recruiting
Phase 3
The effect of tranexamic acid and hydroquinone in melasma
IRCT20180909040979N5Ahvaz University of Medical Sciences48
Recruiting
Phase 3
Comparison of the effect of Botox injection in reducing the size of facial poresarge pores of facial skin.
IRCT20210321050754N1Ahvaz University of Medical Sciences33
Recruiting
Not Applicable
A study to compare efficacy of intradermal Tranexamic acid injections versus topical Tranexamic acid gel versus topical triple combination (Hydroquinone 2 %, Tretinion 0.025%, Flucinolone acetonide 0.01%) cream in patients suffering from melasma
CTRI/2017/07/009158MGM Medical COllege and Hospital180
Not yet recruiting
Not Applicable
Comparative study of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of common warts in childreHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
CTRI/2019/07/020070Himachal Pradesh University